If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,074.00    6.00 (0.56%)
Bid:
1,068.00
Ask:
1,072.00
Spread: 4.00 (0.375%)
Market Cap: £153.88b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Capital increase timeline

27 Oct 2020 17:59

RNS Number : 3972D
Banco Santander S.A.
27 October 2020
 

 

 

Banco Santander, S.A. ("Banco Santander" or the "Bank" or "Santander"), pursuant to the provisions of the Spanish Securities Market Act (Ley del Mercado de Valores), hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

At the general meeting held today, shareholders passed a resolution to increase share capital against reserves (hereinafter, the 'Capital Increase'). If approved by the Bank's Executive Committee, the Capital Increase will be used to pay out approximately 0.10 euros per share in the form of newly issued shares as announced on 29 July 2020. The timeline for the Capital Increase is as follows:

· 12 November 2020. Execution of the Capital Increase and announcement of the number of rights required to receive one share.

· 13 November 2020 (23:59 hours CET). Reference date to participate in the Capital Increase (last trading date). Those who acquired their shares in the Bank by this date (inclusive) and appear as shareholders in the registries of Iberclear at 23:59 CET on 17 November 2020, will be entitled to take part in the Capital Increase.

· 16 November 2020. Start of the rights trading period. Santander shares will trade ex-coupon (ex-date).

· 30 November 2020. End of the rights trading period.

· 4-10 December 2020. Procedures for registering the Capital Increase and admitting new shares to trading on Spanish securities markets.

· 11 December 2020. Start of ordinary trading of the new shares on Spanish securities markets, subject to required authorisation.[1] Shareholders receive their new shares.

 

Boadilla del Monte (Madrid), 27 October, 2020

 

 

[1] Estimated date. The Bank shall also request that the new shares be admitted to trading on any foreign securities markets where it is listed.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDGRUDDGGR
Date   Source Headline
29th Jan 202512:44 pmRNSForm 8.3 - Smith (DS) PLC
29th Jan 202511:07 amRNSNotice of 2024 Results Presentation
23rd Jan 20254:03 pmRNSInvitation to purchase certain instruments
20th Jan 20259:28 amRNSOptional early redemption ISIN XS1793250041
16th Jan 20258:22 amRNSInvitation to purchase certain instruments
15th Jan 20258:29 amRNSOffers to purchase outstanding instruments
7th Jan 20257:44 amRNSOffers to purchase outstanding instruments
31st Dec 202411:16 amRNSTotal Voting Rights
23rd Dec 202412:49 pmRNSFurther re capital reduction
20th Dec 20247:00 amRNSAgreement for the sale of stake in CACEIS
18th Dec 202412:02 pmRNSTotal Voting Rights
11th Dec 20245:46 pmRNSDirector/PDMR Shareholding
11th Dec 202412:00 pmRNSSREP Capital Requirements 2025
4th Dec 20244:16 pmRNSCapital reduction following completion of program
29th Nov 202412:13 pmRNSTotal Voting Rights
28th Nov 202411:08 amRNSBuyback programme: transactions 21-27 Nov
21st Nov 202410:54 amRNSBuyback programme: transactions 14-20 Nov
19th Nov 20245:52 pmRNSDirector/PDMR Shareholding
14th Nov 202411:08 amRNSBuyback programme: transactions 7-13 Nov
11th Nov 20246:29 pmRNSDirector/PDMR Shareholding
7th Nov 202411:10 amRNSBuyback programme: transactions 31Oct-6Nov
6th Nov 20242:34 pmRNSForm 8.3 - Smith (DS) PLC
31st Oct 20242:47 pmRNSTotal Voting Rights
31st Oct 202410:02 amRNSBuyback programme: transactions 24-30 Oct
29th Oct 20247:00 amRNS3Q 2024 Financial report & Earnings presentation
29th Oct 20247:00 amRNSThird Quarter 2024 Results - Press release
24th Oct 202411:14 amRNSBuyback programme: transactions 17-23 Oct
22nd Oct 202411:11 amRNSNotice of Third Quarter 2024 Results
17th Oct 202411:09 amRNSBuyback programme: transactions 10-16 Oct
16th Oct 20247:06 amRNSOptional early redemption ISIN ES0213900220
10th Oct 202411:08 amRNSBuyback programme: transactions 3-9 Oct
9th Oct 20247:08 amRNSEarly redemption ISIN ES0413900632
3rd Oct 202411:12 amRNSBuyback programme: transactions 26Sep-2Oct
30th Sep 20242:10 pmRNSTotal Voting Rights
30th Sep 20241:40 pmRNSInvitation to purchase certain instruments
26th Sep 202411:05 amRNSBuyback programme: transactions 19-25 Sep
24th Sep 20242:16 pmRNSDividend approval
23rd Sep 20247:33 amRNSInvitation to purchase certain instruments
19th Sep 202411:11 amRNSBuyback programme: transactions 12-18 Sep
12th Sep 202411:08 amRNSBuyback programme: transactions 5-11 Sep
11th Sep 20247:00 amRNSPricing of an accelerated placement of shares
5th Sep 202411:08 amRNSBuyback programme: transactions 27Aug-4Sep
3rd Sep 20245:06 pmRNSEarly redemption ISIN ES0213770011
30th Aug 20242:53 pmRNSTotal Voting Rights
27th Aug 20247:07 amRNSCommencement of a program to repurchase own shares
21st Aug 20249:12 amRNSForm 8.3 - Redrow plc
31st Jul 20245:32 pmRNSTotal Voting Rights
30th Jul 20247:00 amRNSAT1s Contingent Convertible securities
29th Jul 20241:26 pmRNSForm 8.3 - Darktrace PLC
26th Jul 202411:41 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.